Business
PT Kalbe Farma Tbk : Company Update - Q2 2025 Unaudited Results (07-August-2025)
PT Kalbe Farma Tbk : Company Update - Q2 2025 Unaudited Results

About this update from Pt Kalbe Farma Tbk
Aug 2025 PT Kalbe Farma Tbk (KLBF IJ/KLBF.JK) Company Presentation 1 1 YTD Jun 2025 Table of Contents Key Updates 04 Business Strategies 09 Financial Overview 24 Appendix 1 31 Appendix 2 38 3 Key Updates 4 Key updates Business Strategy Financial Updates Appendix I Appendix II More than Half a Century of Providing Wide-Range Healthcare Solutions Corporate Overview Net Sales IDR 17.1 tn 7% Export 93% Domestic 33.3% Distribution & Logistics 23.4% Nutritionals 28.9% Prescription Pharmaceuticals 14.4% Consumer Health Market Capitalization* IDR 71.4 tn | USD 4.4 bn *As of 30 June '25 Free Float* 38.4% Treasury Shares* 3.03% Establishment 1966 IDX Listed 1991 Free Float is calculated as total shares deducted by the majority, affiliated boards, and treasury shares 5 Attention : This is an excerpt of the original content. To continue reading it, access the original document here .
View stock analysis, news, and events for Pt Kalbe Farma Tbk